{"product_id":"cleveland-clinic-28th-annual-diabetes","title":"Cleveland Clinic 28th Annual Diabetes Day 2024","description":"\u003ch1 class=\"product_title entry-title\"\u003eCleveland Clinic 28th Annual Diabetes Day 2024\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eInclude: 4 videos + 20 pdfs, size: 6.85 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: primary care physicians, endocrinologists, diabetes educators, pharmacists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Sample video: \u003cspan style=\"color: #0000ff;\"\u003e\u003ca href=\"https:\/\/medustudent.com\/contact_us\/\" style=\"color: #0000ff;\"\u003econtact me\u003c\/a\u003e\u003c\/span\u003e for sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch3\u003eOverview\u003c\/h3\u003e\n\u003cstrong\u003eThe 28th annual Diabetes Day: Therapeutics, Technology and Surgery \u003c\/strong\u003eis presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eA review of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, new insulins, and continuous glucose monitoring updates.\u003c\/li\u003e\n\u003cli\u003eNew data regarding metformin in pregnancy will be discussed.\u003c\/li\u003e\n\u003cli\u003eImportance of maintaining muscle mass during obesity management.\u003c\/li\u003e\n\u003cli\u003eGastroparesis associated with GLP-1 therapy and its effect on pre-op management.\u003c\/li\u003e\n\u003cli\u003eNew roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists in preserving cardiac function and preventing strokes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThis year’s curriculum will also feature discussions about:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eResearch from Cleveland Clinic on non-nutritive sweeteners.\u003c\/li\u003e\n\u003cli\u003eNew treatment for nephropathy.\u003c\/li\u003e\n\u003cli\u003ePre-prandial vs post prandial exercise.\u003c\/li\u003e\n\u003cli\u003eDiabetes and dementia.\u003c\/li\u003e\n\u003cli\u003eMental health and diabetes.\u003c\/li\u003e\n\u003cli\u003eEffects of high-fat and high-protein diets on glucose control.\u003c\/li\u003e\n\u003cli\u003eDermatologic considerations in diabetes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.\u003cbr\u003e\u003cbr\u003eThere will be an optional workshop on continuous glucose monitoring designed for healthcare providers to advance the care of their patients with diabetes using continuous glucose monitoring (CGM) and other diabetes technology.\u003cbr\u003e\u003cbr\u003eIn addition to receiving speaker slides both pre- and post-course, participants will receive access to the recordings of the presentations post-course (non-CME).\u003cbr\u003e\u003ch3\u003eAttendees will be able to:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the efficacy and side effects of therapeutic interventions for Type 1 and Type 2 diabetes, including new insulins, closed-loop insulin pumps, smart pens, and islet and pancreas transplants.\u003c\/li\u003e\n\u003cli\u003eAnalyze new therapies and critically appraise the roles of SGLT-2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists to preserve renal and cardiac function.\u003c\/li\u003e\n\u003cli\u003eAssess goals and management strategies for treating renal insufficiency in patients with diabetes.\u003c\/li\u003e\n\u003cli\u003eEvaluate the impact of weight loss treatment options, including muscle mass preservation, in patients with Type 2 diabetes.\u003c\/li\u003e\n\u003cli\u003eCritically appraise the effects of non-nutritive sweeteners.\u003c\/li\u003e\n\u003cli\u003eDiscuss the impact and define treatment strategies for dermatologic manifestations, neurological impairment such as dementia and stroke, and managing pregnancy for patients with diabetes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho should attend?\u003c\/h3\u003e\n\u003cbr\u003eThis activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ebrochure.pdf\u003c\/li\u003e\n\u003cli\u003eCardiovascular Outcome with Semaglutide in Patients With Obesity Without Diabetes- The SELECT Trial.pdf\u003c\/li\u003e\n\u003cli\u003eDermatologic Manifestations in Diabetes and How to Treat.pdf\u003c\/li\u003e\n\u003cli\u003eDiabetes Management in People Living With Dementia.pdf\u003c\/li\u003e\n\u003cli\u003eGastroparesis in Glp-1 Therapy and Its Implications for Surgery.pdf\u003c\/li\u003e\n\u003cli\u003eHidden Cushings in DM2. Who and How to Evaluate.pdf\u003c\/li\u003e\n\u003cli\u003eManagement of Diabetes in Chronic Kidney Disease.pdf\u003c\/li\u003e\n\u003cli\u003eMetformin in Pregnancy, New Data.pdf\u003c\/li\u003e\n\u003cli\u003eNew Incretin Therapies.pdf\u003c\/li\u003e\n\u003cli\u003eNonnutritive Sweeteners.pdf\u003c\/li\u003e\n\u003cli\u003ePart 1.mp4 (2 hours)\u003c\/li\u003e\n\u003cli\u003ePart 2.mp4 (2 hours)\u003c\/li\u003e\n\u003cli\u003ePart 3.mp4 (1 hours 30 minutes)\u003c\/li\u003e\n\u003cli\u003ePart 4.mp4 (2 hours)\u003c\/li\u003e\n\u003cli\u003ePreserving Muscle Mass With Weight Loss.pdf\u003c\/li\u003e\n\u003cli\u003ePreventing Stroke. A New Diabetes Therapeutic Outcome Goal.pdf\u003c\/li\u003e\n\u003cli\u003eSGLT2- Inhibitors and Normoglycemic DKA.pdf\u003c\/li\u003e\n\u003cli\u003eUltra Long-Acting Insulin, How to Dose.pdf\u003c\/li\u003e\n\u003cli\u003eUse of Insulin Pumps; Innovations in the Last Year.pdf\u003c\/li\u003e\n\u003cli\u003eWhy is Weight Loss so Difficult in DM2..pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 1 – CGM Updates.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 1 – Effect of High-Fat and High-Protein Meals on Glucose Control.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 2 – Debate- Pre-prandial vs Post Prandial Exercise.pdf\u003c\/li\u003e\n\u003cli\u003eWorkshop 2 – Mental Health and Diabetes.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e*Detail:\u003cbr\u003e\u003ctable border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"agenda agendaBorderColor\" id=\"day1-table\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"header\"\u003e\n\u003ctd class=\"agendaBorderColor agendaRowShade borderBottom1px\" colspan=\"2\" height=\"auto\"\u003e\n\u003ch3 class=\"white\"\u003eThursday, May 2, 2024\u003cbr\u003e\u003cem class=\"agenda-alltimes\"\u003eAll times in Eastern Time\u003c\/em\u003e\n\u003c\/h3\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\" width=\"20%\"\u003e7:00 – 7:45 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eOptional Non-CME Breakfast Satellite\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eAvailable for in person attendance only\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e7:00 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRegistration\/Continental Breakfast\/Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e7:55 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eWelcome and Introduction\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eRobert S. Zimmerman, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e8:00 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eMetformin in Pregnancy, New Data\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eStacey Ehrenberg, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e8:20 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eSGLT2- Inhibitors and Normoglycemic DKA\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eAdi Mehta, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e8:40 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eUltra Long-Acting Insulin, How to Dose\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eMarwan Hamaty MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e9:00 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eNonnutritive Sweeteners\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eStanley Hazen, MD, PhD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e9:30 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eNew Incretin Therapies\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eRobert S. Zimmerman, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e10:00 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRefreshment Break\/Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e10:15 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eDiabetes Management in People Living With Dementia\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWilly Marcos Valencia, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e10:35 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003ePreventing Stroke. A New Diabetes Therapeutic Outcome Goal\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eKevin M. Pantalone, DO\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e11:00 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eWhy is Weight Loss so Difficult in DM2?\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eOscar Morey Vargas, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e11:30 am\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eGastroparesis in Glp-1 Therapy and Its Implications for Surgery\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eMona Gossmann, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e12:00 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eManagement of Diabetes in Chronic Kidney Disease\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eM. Luiza Caramori, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e12:30 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eLunch\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e12:45 – 1:30 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eOptional Non-CME Lunch Satellite\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eAvailable for in person attendance only\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eDiabetes Technology\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e1:30 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eUse of Insulin Pumps; Innovations in the Last Year\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eDiana Isaacs, PharmD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003ch4\u003eConcurrent Workshops\u003c\/h4\u003e\n\u003cbr\u003e(live stream attendees will have access to one workshop which will be determined closer to the event)\u003cbr\u003e\u003ch4\u003e\u003cstrong\u003eWorkshop 1\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e2:05 pm\u003cbr\u003eCGM Updates\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eKevin Malloy, PharmD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2:35 pm\u003cbr\u003eEffect of High-Fat and High-Protein Meals on Glucose Control\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eLeann Olansky, MD\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eWorkshop 2\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e2:05 pm\u003cbr\u003eMental Health and Diabetes\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eEmily Durfey, LSW\u003cbr\u003eStephanie Ash, MSW, LSW\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2:35 pm\u003cbr\u003eDebate: Pre-prandial vs Post Prandial Exercise\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eShannon Browne\u003cbr\u003eBradley Heiss\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e3:05 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRefreshment Break\/Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e3:20 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003ePreserving Muscle Mass With Weight Loss\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eMarcio Griebeler, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e3:45 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eCardiovascular Outcome With Semaglutide in Patients With Obesity Without Diabetes: The SELECT Trial\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eA. Michael Lincoff MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e4:15 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eHidden Cushings in DM2. Who and How to Evaluate\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eKeren Zhou, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e4:45 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eDermatologic Manifestations in Diabetes and How to Treat\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eMarilyn Wickenheiser, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"right\"\u003e5:15 pm\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eAdjourn\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954402103394,"sku":"MED-AMB02770","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/40PhotoFixerBot_19-00-00_UTC-1-scaled.jpg?v=1779375524","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-28th-annual-diabetes","provider":"Meducourse","version":"1.0","type":"link"}